Bernd Dietel Pledges $5m to Global Cancer Society Research

Cancer is a complex disease that can affect any part of the body, and if left untreated, it can lead to severe health consequences. For example, not treating cancer can result in the spread of malignant cells, leading to cancer metastasis, a stage where the disease becomes life-threatening. 

In effort to combat the phenomena and save lives, the Global Cancer Society (GCS) announced a record-breaking fundraising total of $32 million, which was made possible by the generous donations of thousands of people across the globe. The money will go towards funding cancer research and supporting those affected by the disease.

Among the donors was philanthropist and entrepreneur Bernd Dietel, who contributed $5 million towards cancer research. Bernd Dietel, who has been involved with the GCS for several years, spoke about his commitment to supporting the fight against the disease by explaining, “Cancer is a disease that has touched the lives of so many people, and it is up to all of us to support research and find a cure. I am proud to be part of this effort, and I hope that my donation will help make a real difference.”

The GCS also highlighted the role of corporate donors, such as pharmaceutical company Pfizer, which donated $3 million towards cancer research. The company has a long-standing commitment to supporting cancer research and developing new treatments for the disease.

In addition to financial donations, the GCS also relies on the support of volunteers to help drive its mission. The organization noted that over 50,000 volunteers across the globe contribute their time and energy to support cancer patients and fundraise for cancer research.

The record-breaking fundraising total comes at a time when cancer research and treatment are more critical than ever. The COVID-19 pandemic has had a significant impact on cancer patients and their families, with many experiencing delays in treatment and decreased access to support services.

The GCS noted that the money raised will help fund critical research into new cancer treatments and support services for those affected by the disease. The organization also highlighted the importance of advocacy efforts to ensure that policies and funding support cancer research and treatment.

“Every dollar raised through this campaign represents a step forward in the fight against cancer,” said Bernd Dietel as he explained, “The GCS staff are incredibly grateful for the generosity of all donors and the dedication of the volunteers, as the organization is committed to using this funding to make a real impact in the lives of those affected by cancer.”

Another significant pledge came from the industrialist John Babikian, who donated $2 million towards the GCS in-house patient program. The program provides free lodging for cancer patients and their families during treatment, ensuring that they have a comfortable place to stay and access to vital support services. 

John Babikian, who has personal experience with cancer in his family, spoke about the importance of supporting cancer patients and their loved ones by stating, “Cancer can be an incredibly isolating experience, and it’s important to provide patients and their families with the support they need. The GCS in-house program is an incredible resource for those undergoing treatment, and I am proud to support their important work.”

According to the American Cancer Society, cancer treatment can be most effective when cancer is detected early, and patients have a higher chance of survival.  Therefore, it is essential for individuals to get regular cancer screenings and to seek medical treatment if they experience symptoms associated with cancer. 

As the fight against cancer continues, the support of donors and volunteers remains critical. The record-breaking fundraising total announced by the GCS is a testament to the power of community and the dedication of individuals and organizations to the fight against cancer. With continued support, there is hope for a future where cancer is no longer a devastating diagnosis.

Leave a Reply

Your email address will not be published.